首页> 外文期刊>IJC Heart & Vasculature >The clinical value of the PRECISE-DAPT score in predicting long-term prognosis in patients with acute myocardial infarction
【24h】

The clinical value of the PRECISE-DAPT score in predicting long-term prognosis in patients with acute myocardial infarction

机译:急性心肌梗死患者长期预后的精确-APT评分的临床价值

获取原文
           

摘要

Background The predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score predicts the risk of bleeding in patients treated with dual antiplatelet therapy after percutaneous coronary intervention. Although the PRECISE-DAPT score is expected to be useful beyond its original field, long-term prognostic value of this score in patients with acute myocardial infarction (AMI) remains unclear. In the current study, we aimed to investigate the performance of the PRECISE-DAPT score in predicting the long-term prognosis in patients with AMI.Method s and resultsConsecutive 552 patients with AMI, who had been discharged from our institution, were enrolled. We divided the patients into three groups, based on their PRECISE-DAPT scores: the low (PRECISE-DAPT?
机译:背景技术预测经过支架植入和随后的双抗血小板治疗(精确-DAPT)评分的预测出血并发症预测,经皮冠状动脉介入后用双抗血小板治疗治疗的患者出血的风险。虽然预期精确的DAPT得分超出其原始领域,但急性心肌梗死患者(AMI)患者的这种分数的长期预后价值仍不清楚。在目前的研究中,我们旨在探讨预测AMI的患者的长期预后的精确DAPT评分的表现。已经注册了从我们所机构发出的AMI的AMI患者的长期预后。我们将患者分为三组,基于它们的精确性分数:低(精确-DAPT?<17),中间(17-24)和高(≥25)得分组。 Kaplan-Meier分析(平均随访1424?天)揭示了全导致死亡率在高分组中最陡峭地增加,后面是中间和低分群(P?<0.001)。调整可能的混淆因子后,中间体或高分组的死亡率高于低分组(HR 2.945,95%CI 1.182-7.237,P?0.020,以及HR 5.567,95%CI 2.644-11.721 ,P?<〜0.001分别)。结论SIN患者AMI,高精度-DAPT得分与较高的长期全导致死亡率相关。精确-DAPT评分对于预测全导致死亡率以及出血的风险分层是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号